Skip to content
Backed by the Science

Does creatine cause hair loss?

Not enough evidence
Evidence confidenceLow

Further research is likely to change the conclusion.

How we rated this ▾
Certainty of evidence across the five GRADE domains
DomainRatingWhy
Risk of biasSeriousThe single relevant trial was small and was not designed to study hair; the remaining sources are narrative rather than systematic.
InconsistencyNot seriousSources do not conflict. There is simply almost nothing here to be inconsistent about.
IndirectnessVery seriousEvery source measures hormones or reports absence of complaints. Not one measured hair density, shedding, or diagnosed hair loss.
ImprecisionVery seriousThe originating trial randomized twenty participants over three weeks, which cannot detect a hair outcome that develops over years.
Publication biasSeriousThe relevant secondary sources are authored by researchers with sports-nutrition industry ties, and no registered trial has tested the question directly.

No published study has measured whether creatine supplementation causes hair loss. The concern traces to a single small trial that found a rise in DHT, a hormone linked to male pattern baldness, but that trial never measured hair. Later reviews report no hair-loss signal, though none looked directly.

3 studies analysed1 human trialLast reviewed

What the evidence shows

  • The question has not been tested. That is different from having been tested and answered no.
  • One 2009 trial in twenty rugby players is the entire origin of the concern, and it measured hormones, not hair.
  • A DHT increase is a plausible mechanism, not a demonstrated outcome.

Why scientists think this

Dihydrotestosterone is the androgen most strongly implicated in male pattern hair loss, acting on genetically susceptible follicles to shorten the growth phase.

If creatine raised DHT persistently, a hair effect in susceptible people would be biologically plausible. Plausibility is not evidence that it happens.

The 2009 hormonal finding has not been consistently reproduced, so even the first link in that chain is unsettled.

Where studies disagree

Good-quality studies do not always agree. Where they conflict, we show the conflict rather than picking the tidier answer.

Whether the absence of reported hair loss is reassuring

One reading

Reviews and position statements treat the absence of hair-loss reports across many trials as evidence that the effect does not occur.

The other

Those trials never measured hair, ran for weeks rather than years, and mostly enrolled young men — so the absence of reports reflects the absence of measurement.

The two positions are answering different questions: whether harm was observed, versus whether harm was looked for.

What we still don’t know

  • No study has measured hair density, shedding rate, or diagnosed androgenetic alopecia in people taking creatine.
  • The originating trial enrolled twenty young male athletes for three weeks, a population and timescale unsuited to detecting hair changes.
  • The hormonal finding itself has not been reliably replicated, so the mechanism's first step is uncertain.
  • People genetically susceptible to pattern hair loss are the group of interest, and no study has isolated them.
  • Most secondary sources on this question carry sports-nutrition industry ties.

What would change our mind

  • A randomized trial measuring hair density or standardized shedding counts over twelve months or longer in adults taking creatine.
  • A large prospective cohort tracking diagnosed androgenetic alopecia among long-term creatine users versus non-users.
  • Consistent replication of the DHT increase across several independent trials, which would strengthen the mechanistic case enough to warrant a direct trial.
  • Any evidence isolating people with a genetic predisposition to pattern baldness, the group in whom an effect would be most likely.

The evidence

Every study that informed this assessment, strongest evidence first — including the ones that disagree with our conclusion.

Every study included in this assessment, strongest evidence first
StudyDesignWhat it measuredFindingQuality
van der Merwe et al. 2009

Three weeks of creatine monohydrate supplementation affects dihydrotestosterone to testosterone ratio in college-aged rugby players

Clinical Journal of Sport Medicine

Population
College-aged male rugby players
Participants
20
Intervention
Creatine monohydrate, 25 g/day loading then 5 g/day
Comparator
Placebo
Duration
3 weeks (1 week loading, 2 weeks maintenance)
Effect
Increase in DHT and in the DHT:T ratio versus placebo after loading

Randomized and placebo-controlled, but twenty participants over three weeks, in a narrow population, measuring a hormone rather than the outcome in question.

doi:10.1097/JSM.0b013e3181b8b52f

Randomized controlled trialSerum dihydrotestosterone and the DHT-to-testosterone ratioSurrogate outcomeSupports
Kreider et al. 2017

International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine

Journal of the International Society of Sports Nutrition

Population
General athletic and clinical populations
Intervention
Creatine monohydrate supplementation
Funding
Authors report relationships with supplement industry entities

Position stand from a sports-nutrition body with industry relationships. Absence of a listed adverse effect is weak evidence of absence when nobody has looked.

doi:10.1186/s12970-017-0173-z

GuidelineDocumented adverse effects of creatine supplementationContradictsIndustry ties
Antonio et al. 2021

Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?

Journal of the International Society of Sports Nutrition

Population
General review of the creatine literature
Intervention
Creatine monohydrate supplementation
Funding
Authors report sports-nutrition industry relationships

Narrative rather than systematic, with no pre-specified search strategy, and authored by researchers with sports-nutrition industry relationships. Context only.

doi:10.1186/s12970-021-00412-w

Narrative reviewReported adverse effects across the literature, including androgenic concernsContradictsIndustry ties
How we researched this196 screened → 3 included

Databases searched

PubMed, Europe PMC, OpenAlex — searched · 1990-2026

Search strings

  • creatine[MeSH] AND (alopecia[MeSH] OR hair[MeSH])
  • creatine AND (dihydrotestosterone OR DHT) AND randomized
  • creatine supplementation adverse effects androgenic

Included if

  • Human participants
  • Reports a hair outcome, or an androgenic hormone outcome proposed as a mechanism for hair loss

Excluded if

  • Animal and in-vitro androgen work with no human hair outcome
  • Case reports without supplementation detail
  • Studies of hair-loss treatments unrelated to creatine

Screening

196 records screened → 21 full texts reviewed → 3 included

Notable exclusions

  • Online summaries and supplement-industry articles asserting creatine is 'proven safe for hair'

    Not primary research and not systematic; they cite the same three sources listed here.

  • Rodent studies of androgen signalling in hair follicles

    Animal androgen work cannot answer a human supplementation question, and rodent hair cycling differs substantially from human pattern hair loss.

Written and reviewed by
First published
Last reviewed
Next review due

No external expert reviewer on this page yet. How we assign review.

How AI was used

AI planned the literature search, screened abstracts against our inclusion criteria, extracted study details into the evidence table, drafted this synthesis from that table, and audited every claim against its cited sources. It did not answer from its own knowledge and did not decide what gets published. A human selected the question, checked the evidence table against the sources, and signed off on the verdict. Full disclosure.

Change history

No changes since first publication.